Abstract: A system for controlling a hydraulic supply on a mobile machine comprises electronic load sensing and is configured to enter a predictive mode of control in which the pump supply pressure PSP is increased following a determination that a hydraulic consumer has been actuated irrespective of the reported hydraulic load at the time. The control system is arranged to monitor the load sensing pressure while operative in a predictive mode of control and to revert to a load-sensing-based control of the pump supply in dependence on the value and/or rate of change of the load sensing pressure. A corresponding method of controlling a hydraulic system on a mobile machine is also disclosed.

Abstract: The invention relates to an apparatus configured to receive an input message via the first interface. The input message having a first layer structure and containing an information piece associated with the top layer of the first layer structure, extracting the information piece from the input message by passing the input message through a protocol stack associated with the first layer structure from bottom to top, examining the extracted information piece to obtain an examination result, generating an output message by passing the extracted information piece or an information piece generated on the basis of the extracted information piece through a protocol stack associated with a second layer structure from top to bottom, and sending the output message via the second interface. The generating and/or the sending of the output message are performed as a function of the examination result.

Abstract: The invention relates to an apparatus configured to receive an input message via the first interface. The input message having a first layer structure and containing an information piece associated with the top layer of the first layer structure, extracting the information piece from the input message by passing the input message through a protocol stack associated with the first layer structure from bottom to top, examining the extracted information piece to obtain an examination result, generating an output message by passing the extracted information piece or an information piece generated on the basis of the extracted information piece through a protocol 10 stack associated with a second layer structure from top to bottom, and sending the output message via the second interface. The generating and/or the sending of the output message are performed as a function of the examination result.

Abstract: In an electronic load sensing system for adjusting a pump of a hydraulic supply system on a mobile machine, a pressure sensor forwards an electronic load sensing pressure signal ELSPS indicative of a sensed load sensing pressure LSP to a controller. The system's response to changes in load sensing pressure are damped with different dampening characteristics applied when the ELSPS is indicative of a rising load sensing pressure LSP than when it is indicative of a falling load sensing pressure LSP. The differing characteristics are selected to minimize the delay in adjusting the pump caused by the signal damping for a rising load sensing pressure while maintaining overall stability of the control system.

Abstract: A system for controlling a hydraulic supply on a mobile machine comprises electronic load sensing and is configured to predictively increase the pump supply pressure PSP following a determination that a hydraulic consumer is about to be actuated. The pump supply is increased irrespective of the reported hydraulic load at the time to meet a predicted hydraulic demand of consumer. The control system may revert to a load-sensing-based control of the pump supply after a given time period or in dependence on a predefined operational parameter being met. A corresponding method of controlling a hydraulic system on a mobile machine is also disclosed.

Abstract: A control system for hydraulic supply system which includes electronic load sensing is configured to adjust the pump supply pressure PSP in dependence on a determined rate of increase of a load sensing pressure LSP. Below a threshold value T of the rate of increase of the load sensing pressure LSP, the pump supply pressure PSP is adjusted so that it is higher than the load sensing pressure LSP by a stand-by pressure differential ?Pst. At or above the threshold value T, the pressure differential is increased to include a dynamic pressure differential ?Pdyn in addition to the stand-by pressure differential ?Pst. A method of controlling a hydraulic system is also disclosed.

Abstract: A system for controlling a hydraulic supply on a mobile machine comprises electronic load sensing and is configured to predictively increase the pump supply pressure PSP following a determination that a hydraulic consumer is about to be actuated. The pump supply is increased irrespective of the reported hydraulic load at the time to meet a predicted hydraulic demand of consumer. The control system may revert to a load-sensing-based control of the pump supply after a given time period or in dependence on a predefined operational parameter being met. A corresponding method of controlling a hydraulic system on a mobile machine is also disclosed.

Abstract: A control system for hydraulic supply system (64) which includes electronic load sensing is configured to adjust the pump supply pressure PSP in dependence on a determined rate of increase of a load sensing pressure LSP. Below a threshold value T of the rate of increase of the load sensing pressure LSP, the pump supply pressure PSP is adjusted so that it is higher than the load sensing pressure LSP by a stand-by pressure differential ?Pst. At or above the threshold value T, the pressure differential is increased to include a dynamic pressure differential ?Pdyn in addition to the stand-by pressure differential ?Pst. A method of controlling a hydraulic system is also disclosed.

Abstract: A control system for a mobile agricultural machine having a hydraulic supply system which includes electronic load sensing and headland control assistance is configured to predictively adjust the pump supply when a headland sequence is initiated. The pump supply may be increased irrespective of the reported hydraulic load at the time the headland sequence is initiated to meet a predicted hydraulic demand of the headland sequence. The control system may revert to a load-sensing-based control of the pump supply after a given time period or in dependence on a predefined operational parameter being met. A corresponding method of controlling a hydraulic system on an agricultural mobile machine is also disclosed.

Abstract: The invention relates to an apparatus configured to receive an input message via the first interface. The input message having a first layer structure and containing an information piece associated with the top layer of the first layer structure, extracting the information piece from the input message by passing the input message through a protocol stack associated with the first layer structure from bottom to top, examining the extracted information piece to obtain an examination result, generating an output message by passing the extracted information piece or an information piece generated on the basis of the extracted information piece through a protocol stack associated with a second layer structure from top to bottom, and sending the output message via the second interface. The generating and/or the sending of the output message are performed as a function of the examination result.

Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer, in particular myeloma. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer, in particular myeloma. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer, in particular myeloma. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer, in particular myeloma. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer, in particular myeloma. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer, in particular myeloma. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer, in particular myeloma. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer, in particular myeloma. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer, in particular myeloma. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer, in particular myeloma. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.